Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 16.35% | 127.03 | 0.0% | $2227.08m | |
| BIIB | Biogen, Inc. | 0.84% | 243.78 | 1.7% | $657.15m | |
| AMGN | Amgen, Inc. | 2.04% | 224.81 | 1.3% | $567.96m | |
| GILD | Gilead Sciences, Inc. | 0.89% | 60.03 | 1.0% | $514.37m | |
| NVAX | Novavax, Inc. | 22.51% | 125.69 | 92.9% | $508.55m | |
| BNTX | BioNTech SE | 4.79% | 109.99 | 0.0% | $483.37m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.95% | 226.71 | 1.9% | $475.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.13% | 514.05 | 2.7% | $473.60m | |
| ILMN | Illumina, Inc. | 4.29% | 317.03 | 3.5% | $393.59m | |
| APVO | Aptevo Therapeutics, Inc. | 1.32% | 44.39 | 18.3% | $233.60m | |
| SGEN | Seagen Inc. | 2.22% | 169.12 | 5.8% | $182.62m | |
| EXAS | EXACT Sciences Corp. | 2.00% | 118.19 | 19.6% | $179.47m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.73% | 123.83 | 2.0% | $157.60m | |
| HALO | Halozyme Therapeutics, Inc. | -2.21% | 40.23 | 18.4% | $131.67m | |
| SRNE | Sorrento Therapeutics, Inc. | 18.12% | 8.15 | 1.4% | $127.58m |
Company Profile
La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401 and LJPC-0118. LJPC-501 is the proprietary formulation for angiotensin II. The LJPC-401 is the formulation of hepcidin, which is an endogenous peptide hormone and LJPC-0118 is La Jolla’s investigational product for the treatment of severe malaria. The company was founded in 1989 and is headquartered in San Diego, CA.